200 related articles for article (PubMed ID: 25987090)
1. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
[TBL] [Abstract][Full Text] [Related]
2. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
3. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
4. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.
Wu J; Wu X; Liang W; Chen C; Zheng L; An H
Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770
[TBL] [Abstract][Full Text] [Related]
6. Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
Wu Y; Chen C; Hua X; Zhao C; Min H
BMC Cancer; 2024 Apr; 24(1):537. PubMed ID: 38678238
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
Qiu L; Xu Y; Xu H; Yu B
BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
10. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer.
Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
Jiang Q; Sun Y; Liu X
Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
[No Abstract] [Full Text] [Related]
14. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis.
Ni X; Sun X; Wang D; Chen Y; Zhang Y; Li W; Wang L; Suo J
Clin Transl Oncol; 2019 May; 21(5):674-686. PubMed ID: 30392153
[TBL] [Abstract][Full Text] [Related]
16. Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.
Yan Q; Guo K; Feng G; Shan F; Sun L; Zhang K; Shen F; Shen M; Ruan S
Medicine (Baltimore); 2018 Sep; 97(37):e12317. PubMed ID: 30212974
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
18. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.
Zhao M; Liang F; Zhang B; Yan W; Zhang J
Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
[TBL] [Abstract][Full Text] [Related]
20. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis.
Han M; Lv S; Zhang Y; Yi R; Huang B; Fu H; Bian R; Li X
Tumour Biol; 2014 May; 35(5):4589-97. PubMed ID: 24464926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
